Lifeward Ltd. LFWD
Industrial Specialties · IPO 2014 · data as of November 13, 2026
Lifeward Ltd. (LFWD) is a healthcare company listed in the US with a market value of about $11M. In the twelve months to September 30, 2026 it had revenue of $21M and net income of -$33M, a net margin of -155.4%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 38% a year, a 5-year average ROIC of -70%.
About Lifeward
Lifeward is listed in the US and classified in industrial specialties, IPO year 2014. Revenue went from $4M in 2014 to $22M in 2025, growth of about 16.9% a year. It was profitable in 0 of the last 10 years in our data. It spends 15% of revenue on research and development.
Score: 1.2 / 5
Checks passed
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21M | $22M | $26M | $14M | $6M | $6M | $4M | $5M | $7M | $8M | $6M |
| Net income | -$33M | -$20M | -$29M | -$22M | -$20M | -$13M | -$13M | -$16M | -$22M | -$25M | -$33M |
| Free cash flow | -$20M | -$17M | -$22M | -$21M | -$18M | -$12M | -$13M | -$15M | -$15M | -$22M | -$27M |
| EPS (diluted) | $-15.43 | $-7.03 | $-10.22 | $-7.82 | $-6.91 | $-4.50 | $-4.58 | $-5.49 | $-7.65 | $-8.73 | $-11.48 |
| Net margin | -155.4% | -90.4% | -112.8% | -159.8% | -355.1% | -213.5% | -295.4% | -319.1% | -331.2% | -318.8% | -553.8% |
| ROIC | — | -153.3% | -117.5% | -48.8% | -21.9% | -11.1% | -40.6% | -56.3% | -180.7% | -91.2% | -91.5% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 2 analysts is $20.00, 393% above the current price; targets range from $10.00 to $30.00; the consensus rating is “none”; expected EPS is $-5.02 for the fiscal year ending December 31, 2026.
Frequently asked questions
Does Lifeward pay a dividend?
Not currently.
Is Lifeward a good stock to buy?
We do not give buy or sell advice. Lifeward scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.